“Low T” and Prescription Testosterone : Public Viewing of the Science Does Matter - EveryONE
▻http://blogs.plos.org/everyone/2014/08/06/low-t-prescription-testosterone-public-viewing-science-matter
Sur l’inestimable valeur de l’"#open_access" pour la science.
... if we examine citations and post-publication commentary seven months since publication, the study has already accumulated 20 citations, more than any other article published in this timeframe. In addition to accumulating citations, the article has prompted researchers to call for additional, more definitive studies: an article published in The Lancet Diabetes and Endocrinology cited the PLOS ONE and JAMA articles and declared an urgent need for large clinical trials of testosterone. Last but not least, the article has stimulated significant post-publication commentary from readers who have analyzed and critiqued the methodology and characteristics of the cohort, spurring further discussion and research, and effectively moving post-publication peer review in a forward direction.
Therefore, the value of this article may not lie strictly in its views, shares, citations, or even saves, or any combination or calculation thereof, but instead in its open access visibility to the public, healthcare providers, federal agencies, and media outlets. Anyone, anywhere in the world with Internet access can read this article and its surrounding discussion and then decide for themselves how to respond and react, and that alone is worth more than any level of metrics combined.